1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

Confirmed Speakers


Keynote Speaker

Targeting RNA With Small Molecules Using Affinity-Selection Mass Spectrometry (KL01)
Dr Elliott B. NICKBARGDr Elliott B. NICKBARG
(MERCK RESEARCH LABORATORIES, Boston, United States)

Read more

Plenary Speakers

Accelerating Drug Discovery with the Integration of Affinity Selection Mass Spectrometry (PL02)
Dr Damian HOUDEDr Damian HOUDE
(RELAY THERAPEUTICS, Cambridge, United States)

Read more
Fishing from an Exclusive Pond Using AS-MS (PL03)
Dr Didier ROCHEDr Didier ROCHE
(EDELRIS, Lyon, France)

Read more
Adapting the AS-MS Technology to GPCR Ligand Discovery (PL04)
Prof. Wenqing SHUIProf. Wenqing SHUI
(SHANGHAITECH UNIVERSITY, Shanghai, China)

Read more
MALDI-TOF AS-MS – a Viable Alternative for LC-MS-based Workflows? (PL06)
Dr Roman SIMONDr Roman SIMON
(BOEHRINGER INGELHEIM PHARMA, Biberach/Riß, Germany)

Read more
Lessons Learned from Pfizer’s Experience in utilizing Affinity Selection by Mass Spectrometry for Hit Identification (PL05)
Dr Matthew D. TROUTMANDr Matthew D. TROUTMAN
(PFIZER, Groton, United States)

Read more
Discovery of Bioactive Natural Products Using Affinity Selection-Mass Spectrometry (PL01)
Prof. Richard  VAN BREEMENProf. Richard VAN BREEMEN
(OREGON STATE UNIVERSITY, Corvallis, United States)

Read more

Organised by

Sponsored by

Copyright 2022 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys